| Literature DB >> 25910229 |
Susan I Jarvi1, William C Pitt2, Margaret E Farias1, Laura Shiels3, Michael G Severino1, Kathleen M Howe1, Steven H Jacquier1, Aaron B Shiels4, Karis K Amano1, Blaine C Luiz1, Daisy E Maher1, Maureen L Allison1, Zachariah C Holtquist1, Neil T Scheibelhut1.
Abstract
The nematode Angiostrongylus cantonensis is a rat lungworm, a zoonotic pathogen that causes human eosinophilic meningitis and ocular angiostrongyliasis characteristic of rat lungworm (RLW) disease. Definitive diagnosis is made by finding and identifying A. cantonensis larvae in the cerebral spinal fluid or by using a custom immunological or molecular test. This study was conducted to determine if genomic DNA from A. cantonensis is detectable by qPCR in the blood or tissues of experimentally infected rats. F1 offspring from wild rats were subjected to experimental infection with RLW larvae isolated from slugs, then blood or tissue samples were collected over multiple time points. Blood samples were collected from 21 rats throughout the course of two trials (15 rats in Trial I, and 6 rats in Trial II). In addition to a control group, each trial had two treatment groups: the rats in the low dose (LD) group were infected by approximately 10 larvae and the rats in the high dose (HD) group were infected with approximately 50 larvae. In Trial I, parasite DNA was detected in cardiac bleed samples from five of five LD rats and five of five HD rats at six weeks post-infection (PI), and three of five LD rats and five of five HD rats from tail tissue. In Trial II, parasite DNA was detected in peripheral blood samples from one of two HD rats at 53 minutes PI, one of two LD rats at 1.5 hours PI, one of two HD rats at 18 hours PI, one of two LD rats at five weeks PI and two of two at six weeks PI, and two of two HD rats at weeks five and six PI. These data demonstrate that parasite DNA can be detected in peripheral blood at various time points throughout RLW infection in rats.Entities:
Mesh:
Year: 2015 PMID: 25910229 PMCID: PMC4409314 DOI: 10.1371/journal.pone.0123064
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of the rat identification and measurements recorded during the trial including gender, number of worms recovered at necropsy, body weights prior to infection and at 6 weeks PI, spleen measurements and treatment group (C control, LD low dose, HD high dose).
| Trial | Rat ID | Gender | Number of worms | Body wt | Body weight (g) 6 wks PI | Change in body weight | Spleen weight (mg) | Spleen length (mm) | Treatment |
|---|---|---|---|---|---|---|---|---|---|
| I | 42 | M | 0 | 156.0 | 176.3 | 20.3 | 162.2 | 22.0 | C |
| I | 46 | m | 0 | 169.8 | 170.2 | 0.4 | 144.8 | 21.7 | C |
| I | 71 | f | 0 | 163.8 | 198.3 | 34.5 | 277.8 | 26.8 | C |
| I | 75 | m | 0 | 150.2 | 160.7 | 10.5 | 210.0 | 22.7 | C |
| I | 80 | m | 0 | 144.5 | 170.8 | 26.3 | 196.6 | 24.2 | C |
| II | 165 | m | 0 | 157.9 | 179.6 | 21.7 | 133.0 | 25.0 | C |
| II | 157 | f | 0 | 137.4 | 115.1 | -22.3 | 295.0 | 25.0 | C |
| Mean | 167.3 | 13.1 | 202.8 | 23.9 | |||||
| I | 43 | m | 4 | 153.9 | 153.5 | -0.4 | 193.7 | 21.0 | LD |
| I | 47 | f | 2 | 140.0 | 165.8 | 25.8 | 279.9 | 26.5 | LD |
| I | 72 | f | 6 | 186.8 | 197.6 | 10.8 | 369.7 | 28.6 | LD |
| I | 76 | m | 4 | 179.7 | 190.3 | 10.6 | 421.0 | 26.5 | LD |
| I | 96 | f | 9 | 169.9 | 162.4 | -7.5 | 293.0 | 24.8 | LD |
| II | 127 | f | 0 | 150.8 | 160.2 | 9.4 | 208.0 | 22.0 | LD |
| II | 133 | m | 16 | 207.0 | 226.6 | 19.6 | 565.0 | 33.0 | LD |
| Mean | 5.9 | 179.5 | 9.8 | 332.9 | 26.1 | ||||
| I | 44 | f | 8 | 133.6 | 130.3 | -3.3 | 241.1 | 24.1 | HD |
| I | 48 | f | 21 | 133.0 | 137.2 | 4.2 | 451.4 | 28.7 | HD |
| I | 73 | f | 12 | 143.5 | 145.0 | 1.5 | 338.2 | 27.6 | HD |
| I | 77 | f | 57 | 130.8 | 128.8 | -2.0 | 350.0 | 23.6 | HD |
| I | 82 | f | 16 | 137.4 | 153.4 | 16.0 | 388.6 | 28.0 | HD |
| II | 123 | f | 47 | 145.8 | 143.8 | -2.0 | 500.0 | 28.0 | HD |
| II | 132 | m | 19 | 144.7 | 145.6 | 0.9 | 624.0 | 39.0 | HD |
| Mean | 26 | 140.6 | 2.2 | 413.3 | 28.4 |
*The mean number of adult worms isolated from HD rats was significantly greater (p = 0.001, F = 10.11, DF = 2) than those isolated from LD or C groups. The mean spleen weight of HD rats was significantly greater (p = 0.011, F = 5.92. DF = 2) than uninfected controls.
** Rats in trial I were ~5 months of age and rats in trial II were ~6 months of age at the time of body weight measurement.
Fig 1Mean spleen weights (g) of control, low dose and high dose rats.
Mean spleen weight of the HD was significantly greater (p = 0.011, F = 5.92. DF = 2) than the uninfected controls. Mean spleen weight of control rats was 202.8 mg, of LD rats was 332.9 mg and of HD rats was 373.3 mg. Standard error bars are indicated.
Fig 2Mean number of adult worms isolated from heart and lungs.
The mean number of adult worms isolated from the heart and lungs of HD rats was significantly higher (p = 0.001, F = 10.11, DF = 2) than that isolated from LD or control groups. Worm numbers ranged from 0–16 in the LD group and 8–57 in the HD group. Mean worm numbers of control rats was 0, of LD rats was 5.9, and of HD rats was 26. Standard error bars are indicated.
Results of qPCR for detection of RLW DNA in blood or tissue of rats involved in Trial I and Trial II.
| Trial I n = 5 rats/treatment | Trial II n = 2 rats/treatment | |||||
|---|---|---|---|---|---|---|
| Treatment | Time PI | Number of qPCR replicates/ rat | Number of rats positive | Time PI | Number of qPCR replicates/ rat | Number of rats positive |
| Control | pre-bleed | 4 | 0 | pre-bleed | 4, 8 | 0 |
| 4–7 hrs | 4 | 0 | 45–55 mins | 4 | 0 | |
| 21–24 hrs | 4 | 0 | 2–2:20 hrs | 4 | 0 | |
| day 2 | 4 | 0 | 14–15 hrs | 4 | 0 | |
| day 3 | 4 | 0 | 16–17 hrs | 4 | 0 | |
| week 1 | 4 | 0 | 18–19 hrs | 4 | 0 | |
| week 2 | 4 | 0 | Week 4 | 2, 4 | 0 | |
| wk 6 cardiac | 2 | 0 | Week 5 | 2 | 0 | |
| wk 6 tail | 8 | 0 | Week 6 | 2, 4 | 0 | |
| Low dose | pre-bleed | 4 | 0 | pre-bleed | 2 | 0 |
| 4–7 hrs | 4 | 0 | 30–35 mins | 2 | 0 | |
| 21–24 hrs | 4 | 0 | 1:30 hrs | 2, 6 | 1 | |
| day 2 | 4 | 0 | 14–15 hrs | 2 | 0 | |
| day 3 | 4 | 0 | 16–17 hrs | 2 | 0 | |
| week 1 | 4 | 0 | 18–19 hrs | 2 | 0 | |
| week 2 | 4 | 0 | Week 4 | 2, 4 | 0 | |
| week 6 cardiac | 2 | 5 | Week 5 | 4 | 1 | |
| wk 6 tail | 12 | 3 | Week 6 | 2, 4 | 2 | |
| High dose | pre-bleed | 4 | 0 | pre-bleed | 2 | 0 |
| 4–7 hrs | 4 | 0 | 50–60 mins | 2, 6 | 1 | |
| 21–24 hrs | 4 | 0 | 2–2:15 hrs | 2 | 0 | |
| day 2 | 4 | 0 | 14–15 hrs | 2 | 0 | |
| day 3 | 4 | 0 | 16–17 hrs | 2 | 0 | |
| week 1 | 4 | 0 | 18–19 hrs | 2 | 1 | |
| week 2 | 4 | 0 | Week 4 | 2 | 0 | |
| week 6 cardiac | 2 | 5 | Week 5 | 4, 5 | 2 | |
| wk 6 tail | 12 | 5 | Week 6 | 2 | 2 | |
High dose infection (HD, 50 larvae/ml gavage), low dose (LD, 10 larvae/ml gavage), control (C, 0 larvae/ml gavage).
1One extraction per individual except wk 6 tail: tail tissue, which had two extractions per individual for controls, 3 extractions per individual for infected.
2Positive = clear signal in large proportion of replicates
3If the number of replicate qPCR tests differed between the two individuals, they are reported separately.